Neuropeptide S: A novel modulator of stress and arousal

References

• Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, Katsuura G, Makino S, Fujino MA, Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001; 74: 143–147
   PubMed Web of Science ®Google Scholar
• Beck B, Fernette B, Stricker-Krongrad A. Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochem Biophys Res Commun 2005; 332: 859–865
   Google Scholar
• Berretta S. Cortico-amygdala circuits: Role in the conditioned stress response. Stress 2005; 8: 221–232
   PubMed Web of Science ®Google Scholar
• Bourin M, Briley M. Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs. Hum Psychopharmacol 2004; 19: 135–139
   Google Scholar
• Brunton PJ, Bales J, Russell JA. Neuroendocrine stress but not feeding responses to centrally administered neuropeptide Y are suppressed in pregnant rats. Endocrinology 2006; 147: 3737–3745
   PubMed Web of Science ®Google Scholar
• Carlini VP, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, de Barioglio SR. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun 2004; 313: 635–641
   PubMed Web of Science ®Google Scholar
• Chaouloff F, Durand M, Mormede P. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav Brain Res 1997; 85: 27–35
   Google Scholar
• Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA 1989; 262: 1479–1484
   PubMed Web of Science ®Google Scholar
• Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96: 10911–10916
   PubMed Web of Science ®Google Scholar
• Hanson ES, Dallman MF. Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo–pituitary–adrenal axis. J Neuroendocrinol 1995; 7: 273–279
   Google Scholar
• Hayase T, Yamamoto Y, Yamamoto K. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: Interactions with endogenous cannabinoid receptor ligands. Behav Pharmacol 2005; 16: 395–404
   Google Scholar
• Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 2003; 24: 580–588
   PubMed Web of Science ®Google Scholar
• Karlsson RM, Holmes A, Heilig M, Crawley JN. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav 2005; 80: 427–436
   PubMed Web of Science ®Google Scholar
• Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, Salmikangas P, Makela S, Rehn M, Pirskanen A, Rautanen A, Zucchelli M, Gullsten H, Leino M, Alenius H, Petays T, Haahtela T, Laitinen A, Laprise C, Hudson TJ, Laitinen LA, Kere J. Characterization of a common susceptibility locus for asthma-related traits. Science 2004; 304: 300–304
   PubMed Web of Science ®Google Scholar
• Lowry CA, Moore FL. Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol 2006; 146: 19–27
   PubMed Web of Science ®Google Scholar
• Nakajima M, Inui A, Asakawa A, Momose K, Ueno N, Teranishi A, Baba S, Kasuga M. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 1998; 19: 359–363
   PubMedGoogle Scholar
• Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13–25
   PubMed Web of Science ®Google Scholar
• Paine TA, Jackman SL, Olmstead MC. Cocaine-induced anxiety: Alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol 2002; 13: 511–523
   PubMed Web of Science ®Google Scholar
• Reinscheid RK, Xu YL, Okamura N, Zeng J, Chung S, Pai R, Wang Z, Civelli O. Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther 2005; 315: 1338–1345
   PubMed Web of Science ®Google Scholar
• Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2002; 2: 23–33
   PubMed Web of Science ®Google Scholar
• Rogerio R, Takahashi RN. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacol Biochem Behav 1992; 43: 631–633
   Google Scholar
• Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573–585
   PubMed Web of Science ®Google Scholar
• Saper CB, Chou TC, Scammell TE. The sleep switch: Hypothalamic control of sleep and wakefulness. Trends Neurosci 2001; 24: 726–731
   PubMed Web of Science ®Google Scholar
• Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV, Ghatei MA, Bloom SR. Neuropeptide S stimulates the hypothalamo–pituitary–adrenal axis and inhibits food intake. Endocrinology 2006; 147: 3510–3518
   Google Scholar
• Sorensen G, Lindberg C, Wortwein G, Bolwig TG, Woldbye DP. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J Neurosci Res 2004; 77: 723–729
   PubMed Web of Science ®Google Scholar
• Sudakov SK, Medvedeva OF, Rusakova IV, Terebilina NN, Goldberg SR. Differences in genetic predisposition to high anxiety in two inbred rat strains: Role of substance P, diazepam binding inhibitor fragment and neuropeptide Y. Psychopharmacology (Berl) 2001; 154: 327–335
   Web of Science ®Google Scholar
• Sumnall HR, O'Shea E, Marsden CA, Cole JC. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test. Pharmacol Biochem Behav 2004; 77: 805–814
   Google Scholar
• Sutcliffe JG, de Lecea L. The hypocretins: Setting the arousal threshold. Nat Rev Neurosci 2002; 3: 339–349
   Google Scholar
• Suzuki M, Beuckmann CT, Shikata K, Ogura H, Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 2005; 1044: 116–121
   Google Scholar
• Szelenberger W, Soldatos C. Sleep disorders in psychiatric practice. World Psychiatry 2005; 4: 186–190
   PubMedGoogle Scholar
• Szentirmai E, Hajdu I, Obal F, Jr., Krueger JM. Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats. Brain Res 2006; 1088: 131–140
   PubMed Web of Science ®Google Scholar
• Van der Werf YD, Witter MP, Groenewegen HJ. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 2002; 39: 107–140
   PubMed Web of Science ®Google Scholar
• Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: Different circuits, different purposes. Physiol Behav 2001; 74: 683–701
   PubMed Web of Science ®Google Scholar
• Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O. Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004; 43: 487–497
   PubMed Web of Science ®Google Scholar
• Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK. Distribution of Neuropeptide S receptor mRNA and neurochemical characteristics of Neuropeptide S expressing neurons in the rat brain. J Comp Neurol 2007; 500: 84–102
   PubMed Web of Science ®Google Scholar